echothiophate iodide 1.25 MG/ML Ophthalmic Solution [Phospholine Iodide]
echothiophate iodide
RxCUI: 205739
What the CMS Formulary Data Shows for echothiophate iodide 1.25 MG/ML Ophthalmic Solution [Phospholine Iodide]
Per the CMS 2026 Part D formulary file, echothiophate iodide 1.25 MG/ML Ophthalmic Solution [Phospholine Iodide] (RxNorm concept RXCUI 205739, generic name echothiophate iodide) appears on 15 distinct formulary files spanning 841 Medicare Part D plan offerings - 16.6% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 2 to Tier 5, with a cross-plan average of Tier 4.1.
Real-world access to echothiophate iodide 1.25 MG/ML Ophthalmic Solution [Phospholine Iodide] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 50 Part D beneficiaries filled echothiophate iodide 1.25 MG/ML Ophthalmic Solution [Phospholine Iodide] in 2023, with total plan-and-beneficiary spending of $941,693 and an average per-beneficiary annual cost of $18,833.86. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry echothiophate iodide 1.25 MG/ML Ophthalmic Solution [Phospholine Iodide] today.
Coverage Details
- Formularies covering
- 15
- Plans covering
- 841
- Coverage rate
- 16.6%
- Tier range
- Tier 2 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 50
- Total spending
- $941,693
- Avg per beneficiary
- $18,833.86
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering echothiophate iodide 1.25 MG/ML Ophthalmic Solution [Phospholine Iodide]
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is echothiophate iodide 1.25 MG/ML Ophthalmic Solution [Phospholine Iodide] covered by Medicare Part D?
Yes, echothiophate iodide 1.25 MG/ML Ophthalmic Solution [Phospholine Iodide] is covered by 841 Medicare Part D plans (16.6% of all Part D formularies).
What tier is echothiophate iodide 1.25 MG/ML Ophthalmic Solution [Phospholine Iodide] on Medicare Part D plans?
echothiophate iodide 1.25 MG/ML Ophthalmic Solution [Phospholine Iodide] averages Tier 4.1 across Part D plans, ranging from Tier 2 to Tier 5.
Does echothiophate iodide 1.25 MG/ML Ophthalmic Solution [Phospholine Iodide] require prior authorization?
0% of Part D formularies require prior authorization for echothiophate iodide 1.25 MG/ML Ophthalmic Solution [Phospholine Iodide]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on echothiophate iodide 1.25 MG/ML Ophthalmic Solution [Phospholine Iodide]?
In 2023, total Medicare Part D spending on echothiophate iodide 1.25 MG/ML Ophthalmic Solution [Phospholine Iodide] was $941,693, covering 50 beneficiaries. The average spend per beneficiary was $18,833.86.
Read our methodology - how this data is sourced, computed, and verified.